.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,238,340

« Back to Dashboard

Details for Patent: 7,238,340

Title:Monoamine, diamide, thiol-containing metal chelating agents
Abstract: Therapeutically active thiazole derivatives of formula (I) wherein R.sup.1-R.sup.2, X and X' as are defined in the specification, processes for the preparation thereof, the use thereof in therapy, particularly in the treatment or prophylaxis of disorders characterised by overexpression of transforming growth factor .cndot. (TGF-.cndot.), and pharmaceutical compositions for use in such ##STR00001## therapy.
Inventor(s): McBride; William (Manchester, NH), Dean; Richard T. (Bedford, NH)
Assignee: CIS bio international (Gif-sur-Yvette, FR)
Filing Date:Jun 03, 1994
Application Number:08/253,973
Claims:1. A reagent comprising a targeting moiety covalently linked via a bivalent linking group to a metal chelator in which the metal chelator and the bivalent linking group together have the formula: ##STR00014## wherein: R.sup.1 and R.sup.2 are each independently H, lower alkyl, hydroxyalkyl (C.sub.2 C.sub.4), or alkoxyalkyl (C.sub.2 C.sub.4); R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are independently H, substituted or unsubstituted lower alkyl or phenyl not comprising a thiol group, and one of R.sup.3, R.sup.4, R.sup.5, and R.sup.6 is --L--(CR.sub.2).sub.n- where n is an integer from 1 to 6, and each R is independently H, lower alkyl, or substituted lower alkyl; R.sup.7 and R.sup.8 are each independently H, lower alkyl, lower hydroxyalkyl or lower alkoxyalkyl; X is --NH.sub.2, --NR.sup.1R.sup.2, or --NR.sup.1-Y, where Y is an amino acid, an amino acid amide, or a peptide of from 2 to about 20 amino acids; and L is the bivalent linking group.

2. A reagent according to claim 1, wherein the metal chelator and the bivalent linking group together have the formula: ##STR00015## wherein: R.sup.1 and R.sup.2 are each independently H, lower alkyl, hydroxyalkyl (C.sub.2 C.sub.4) or alkoxyalkyl (C.sub.2 C.sub.4); R.sup.3 and R.sup.4 are independently H, substituted or unsubstituted lower alkyl or phenyl not comprising a thiol group; X is --NH.sub.2, --NR.sup.1R.sup.2, or --NR.sup.1-Y, where Y is an amino acid, an amino acid amide, or a peptide of from 2 to about 20 amino acids; and L is the bivalent linking group.

3. A reagent according to claim 2, wherein the metal chelator and the bivalent linking group together have the formula: ##STR00016## wherein: L is bivalent linking group.

4. A reagent according to claim 1, wherein the metal chelator is selected from the group consisting of (amino acid).sup.1-(amino acid).sup.2-cysteine- and (amino acid).sup.1-(amino acid).sup.2-penicillamine- wherein: (amino acid).sup.1 does not comprise a thiol and is either an .alpha.,.omega.- or a .beta.,.omega.-diamino acid having a free .alpha.-amine or .beta.-amine, and (amino acid).sup.2 is a primary .alpha.- or .beta.-amino acid not comprising a thiol.

5. A reagent according to claim 4, wherein the metal chelator has a formula selected from the group consisting of: -(.epsilon.-Lys)-Gly-Cys-, -(.delta.-Orn)-Gly-Cys-, -(.gamma.-Dab)-Gly-Cys- and -(.beta.-Dap)-Gly-Cys-.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc